Apretude in Thailand: First Injectable Option for HIV Pre-Exposure Prophylaxis (PrEP) Approved by the US FDA
10765
Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)
10765
Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)